HomeOXBDF • OTCMKTS
add
Oxford BioMedica plc
Previous close
$8.65
Year range
$3.15 - $8.65
Market cap
784.05M GBP
Avg Volume
1.11K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
In the news
Financials
Income Statement
Revenue
Net income
| (GBP) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 36.61M | 44.12% |
Operating expense | 27.62M | 6.43% |
Net income | -13.18M | 18.85% |
Net profit margin | -36.00 | 43.70% |
Earnings per share | — | — |
EBITDA | -7.07M | 37.05% |
Effective tax rate | -3.25% | — |
Balance Sheet
Total assets
Total liabilities
| (GBP) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 53.88M | -33.82% |
Total assets | 216.32M | -11.70% |
Total liabilities | 183.59M | 5.66% |
Total equity | 32.73M | — |
Shares outstanding | 106.14M | — |
Price to book | 27.90 | — |
Return on assets | -13.62% | — |
Return on capital | -21.33% | — |
Cash Flow
Net change in cash
| (GBP) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -13.18M | 18.85% |
Cash from operations | 1.82M | 109.26% |
Cash from investing | -119.50K | -103.28% |
Cash from financing | -5.08M | -203.78% |
Net change in cash | -3.39M | 69.64% |
Free cash flow | -2.64M | 68.87% |
About
Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. Wikipedia
Founded
1995
Website
Employees
900
